Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CARMIL Therapeutics
Le Genest-Saint-Isle, Pays de la Loire, Franceatlanpolebiotherapies.eu ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
CARMIL Therapeutics is developing a proprietary technology to enhance the efficacy of cell therapies by engineering therapeutic T lymphocytes. Their approach enables these modified T cells to trigger the CD28 costimulatory signal independently of traditional ligands, improving their function in low-inflammatory environments and conferring resistance to tumor-induced inhibitory signals. The company’s programs are currently at the pre-clinical stage and focus on solid tumors and autoimmune disorders[1][2].
- Therapeutic areas
- OncologyImmunology
- Modalities
- Cell therapies (including CAR-T cells, TCR-engineered T cells, HIT & STAR-engineered T cells, Tumor Infiltrating Lymphocytes (TILs), and CAR-Tregs)
- Industry
- Biotech
02
Partnerships
Actively seeking partners for expansion but no specific partnerships disclosed as of now[2].
Beyond the preview
Go deeper on CARMIL Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CARMIL Therapeutics.